Download presentation
Presentation is loading. Please wait.
1
by Sabah Sallah, and Jim Y. Wan
Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia by Sabah Sallah, and Jim Y. Wan Blood Volume 101(3): February 1, 2003 ©2003 by American Society of Hematology
2
The course of factor VIII inhibitor and factor VIII level in 6 patients with inhibitors against factor VIII.Day 0 corresponds to the first day of treatment with 2-chlorodeoxyadenosine. The course of factor VIII inhibitor and factor VIII level in 6 patients with inhibitors against factor VIII.Day 0 corresponds to the first day of treatment with 2-chlorodeoxyadenosine. Sabah Sallah, and Jim Y. Wan Blood 2003;101: ©2003 by American Society of Hematology
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.